A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease

Cailin H Sibley; Andrea Chioato; Sandra Felix; Laurence Colin; Abhijit Chakraborty; Nikki Plass; Jackeline Rodriguez-Smith; Carmen Brewer; Kelly King; Christopher Zalewski; H Jeffrey Kim; Rachel Bishop; Ken Abrams; Deborah Stone; Dawn Chapelle; Bahar Kost; Christopher Snyder; John A Butman; Robert Wesley; Raphaela Goldbach-Mansky

doi:10.1136/annrheumdis-2013-204877

Article info

Clinical and epidemiological research

Extended report

A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease

Authors

Cailin H Sibley Translational Autoinflammatory Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles
Andrea Chioato Novartis Institutes for BioMedical Research, Basel, Switzerland PubMed articles Google scholar articles
Sandra Felix Novartis Institutes for BioMedical Research, Basel, Switzerland PubMed articles Google scholar articles
Laurence Colin Novartis Institutes for BioMedical Research, Basel, Switzerland PubMed articles Google scholar articles
Abhijit Chakraborty Novartis Institutes for BioMedical Research, Basel, Switzerland PubMed articles Google scholar articles
Nikki Plass Translational Autoinflammatory Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles
Jackeline Rodriguez-Smith Translational Autoinflammatory Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles
Carmen Brewer Otolaryngology Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles
Kelly King Otolaryngology Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles
Christopher Zalewski Otolaryngology Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles
H Jeffrey Kim Otolaryngology Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles
Rachel Bishop National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles
Ken Abrams Novartis Institutes for BioMedical Research, Basel, Switzerland PubMed articles Google scholar articles
Deborah Stone Translational Autoinflammatory Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles
Dawn Chapelle Translational Autoinflammatory Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles
Bahar Kost Translational Autoinflammatory Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles
Christopher Snyder Translational Autoinflammatory Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles
John A Butman Diagnostic Radiology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles
Robert Wesley Clinical Center, National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles
Raphaela Goldbach-Mansky Translational Autoinflammatory Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health, Bethesda, Maryland, USA PubMed articles Google scholar articles

Correspondence to Dr Raphaela Goldbach-Mansky, Translational Autoinflammatory Section, NIH/NIAMS, Building 10 Room 6D47-B, 10 Center Dr., Bethesda, MD 20892, USA; goldbacr{at}mail.nih.gov

View Full Text

Citation

Sibley CH, Chioato A, Felix S, et al

A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease

Annals of the Rheumatic Diseases 2015;74:1714-1719.

Publication history

Received November 11, 2013
Revised March 21, 2014
Accepted April 13, 2014
First published June 6, 2014.

Online issue publication

October 25, 2017

Article Versions

Previous version (25 October 2017).
You are viewing the most recent version of this article.
latest version (25 October 2017).

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password